Trial
NCT01783431
Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Melanoma
Intervention
Poly ICLC
Why stopped
The study was terminated early due to low accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-02